Skip to content

Perioperative Ketamine to Reduce Postoperative Delirium and Depression - The RECOGNISED Study

Perioperative Ketamine to Reduce Postoperative Delirium and Depression in elderly patients undergoing cardiac and major vascular surgery (The RECOGNISED Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12615001074583
Acronym
RECOGNISED
Enrollment
145
Registered
2015-10-13
Start date
2015-06-05
Completion date
2018-01-03
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to invesitgate the neuroprotective effects of ketamine in elderly patients undergoing cardiac and major vascular surgery. Delirium and depression are common effects of cardiac and major vascular surgery. Ketamine is believed to have a protective effect against delirium and depression. Participants will undergo neuropsychological testing prior to surgery and again at day 7 and 3 months postoperatively. Deliriuma and depression will be measured during patient hospital stay. Additionally, inflammatory bloods will be taken to assess the role inflammation plays in the role of postoperative cognitive dysfunction.

Interventions

Participants involved in study will be randomly assigned to either a ketamine group or a control group before undergoing cardiac or major vascular surgery. Ketamine is proposed as a neuroprotective drug from delirium and depression postoperatively as they are a common in the elderly population undergoing cardiac and major vascular surgery. Ketamine/saline will be administered intravenously as a single dose (0.5mg/kg) fifteen minutes following anaesthetic induction. No further alterations or addi

Participants involved in study will be randomly assigned to either a ketamine group or a control group before undergoing cardiac or major vascular surgery. Ketamine is proposed as a neuroprotective drug from delirium and depression postoperatively as they are a common in the elderly population undergoing cardiac and major vascular surgery. Ketamine/saline will be administered intravenously as a single dose (0.5mg/kg) fifteen minutes following anaesthetic induction. No further alterations or additions to anaesthetic or surgical technique are required.

Sponsors

St Vincent's Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients age 60 years or older, scheduled for cardiac or major vascular surgery (greater than 2 hours). 2. Mini Mental State Examination score between 16 and 25 3. Provide written and informed consent. 4. Reside within reasonable prosimity to St Vincent's Hospital Melbourne for neuropsychological testing

Exclusion criteria

1. Prior neurological deficit (eg Stroke) 2. Contraindication to neuropsychological testing such as language, visual or hearing impairment 3. Associated medical problems that may lead to significant complications and subsequent loss to follow-up 4. Anticipated ICU stay greater than 24 hours 5. Patients on psychoactive drugs (not antidepressants) 6. Patients unable to consent independently to their surgery on account of cognitive impairment.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026